New York K 1325: Memorializing Governor Kathy Hochul to proclaim May 12, 2026, as Fibromyalgia Awareness Day in the State of New York

Status: ADOPTED (as of 2026-05-12)

State: New York · Session: 2025-2026 · Bill: K 1325

Sponsors: Rules Committee

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
K01325 Summary:

BILL NOK01325 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORRules (Solages)

&nbsp

COSPNSR

&nbsp

MLTSPNSRButtenschon, Santabarbara

&nbsp

&nbsp

Go to top K01325 Actions:

BILL NOK01325 

&nbsp

05/11/2026referred to calendar

05/12/2026adopted

Go to topK01325 Committee&nbspVotes:

Go to topK01325 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topK01325 Text:

Senate Resolution No. 2081

BY: Senator MAY

 MEMORIALIZING Governor Kathy Hochul to proclaim
 May 12, 2026, as Fibromyalgia Awareness Day in the
 State of New York

 WHEREAS, An estimated 10-12 million people in the United States, and
an estimated 3-6 percent of the world's population, have been diagnosed
with Fibromyalgia, an illness for which there is yet no known cause or
cure; and

 WHEREAS, A chronic syndrome that is increasing at alarming rates,
Fibromyalgia causes debilitating widespread pain and fatigue, has
demonstrated a genetic component, and occurs in women, men, and children
of all ages and ethnicities; and

 WHEREAS, Patients with Fibromyalgia often have to live with
widespread pain throughout their bodies, extreme fatigue, sleep
disorders, digestive difficulties, stiffness and weakness, migraine
headaches, numbness and tingling, and impairment of memory and
concentration; and

 WHEREAS, The average gap between medical research and clinical
practice is 17 years; and

 WHEREAS, It often takes an average of five years to receive a
diagnosis of Fibromyalgia; and

 WHEREAS, There is currently no database that maintains accurate
information regarding the prevalence of Fibromyalgia in New York State,
or the United States; and

 WHEREAS, Many physicians refuse to treat Fibromyalgia patients whose
symptoms tend to increase with lack of appropriate treatments; and

 WHEREAS, According to a fact sheet provided by the National
Fibromyalgia Association, 90% of physicians agree there is a need for
more physician-oriented information, and 82% of physicians agree that
Fibromyalgia is difficult to treat with the tools that are currently
available; and use of complementary and alternative medicine is 2.5
times higher in Fibromyalgia patients; and

 WHEREAS, The NIH reports that average direct costs above insurance,
over a three-month period, added up to $951per patient, which could be
translated in a mean annual cost of $3,804; and

 WHEREAS, Fibromyalgia patients are often misunderstood by the
medical, business, and education communities, primarily due to the lack
of teaching in medical schools about what is currently known regarding
this potentially disabling illness; and

 WHEREAS, Fibromyalgia patients often lose jobs, insurance, homes,
and spouses or significant others due to lack of awareness and
understanding about the potentially devastating impact of Fibromyalgia;
and

 WHEREAS, Patients report that the optimal approach to treating
Fibromyalgia is a Team of Physicians, with traditional and complementary
therapists, tailoring the treatment for each individual patient; this
can be accomplished best in an arrangement that facilitates
communication between the patient and the Team; and

 WHEREAS, The International Institute For Human Empowerment, Inc., a
nonprofit charitable organization in the Capital District of New York,
is dedicated to empowering all who face discrimination as a result of
race, gender, socioeconomic status, age, disabilities, and lifestyle
choices; and

 WHEREAS, The International Institute For Human Empowerment, Inc.,
under the leadership of Sue Shipe, PhD, developed the Fibromyalgia Task
Force of New York State to address inequities in the diagnosis and
treatment of Fibromyalgia patients due to lack of education in medical
schools and continuing education for Physicians; lack of understanding
by society at large; lack of understanding and adequate accommodations
by employers; and lack of legal protections due to the general lack of
recognition of the devastating impact of this illness; and

 WHEREAS, The Fibromyalgia Task Force of New York State serves
patients across the State of New York, provides education and advocacy
nationally, and shares information internationally; and

 WHEREAS, The Fibromyalgia Task Force of New York State is developing
a website for Physicians that will provide a comprehensive overview of
Fibrom

View New York K 1325 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.